Outpatient Profile in Anxiolytic and/or Antidepressant Treatment
Abstract
Prescription of anxiolytic, hypnotic benzodiazepines and antidepressant drugs has experienced a remarkable increase during recent years. Due to their central effects, these drugs are currently being widley used in the treatment of pathologies such as insomnia, anxiety or depression. The object of this study is to draw the profile of outpatients undergoing treatment with any of the aforementioned active principles. Thus, a cross-sectional descriptive epidemiological study was carried out. In this context, patients meeting the study’s inclusión criteria were invited to fill in a questionnaire. During the questionnaire design phase, all technical specifications of the active principles being commercialised in Spain wich fall within the anxiolytic, hypnotic benzodizepines or antidepressant groups were consulted. A total of 104 questionnaires were collected and data compiled and analyzed using a database system.It was noted that the consumption of anxiolytic and antidepressant drugs is more frequent among female patients and that it increases with patients age. Retired people are the greatest consumers of anxiolytic drugs and so are active workers for the antidepressant group. In general, they are long-term treatments. Lorazepam is the anxiolytic drug most frequently prescribed, while Escitalopram is the top one within the antidepressant group.
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
AEMPS: Agencia Española del Medicamento y Productos Sanitarios. Observatorio del Uso de Medicamentos. Utilización de Medicamentos Ansiolíticos e Hipnóticos en España Durante el Periodo 2000-2012. [Internet]. Madrid: AEMPS; 2014 [actualizado 27 enero 2014; citado 10 febrero 2018] Disponible en: https://www.aemps.gob.es/medicamentosUsoHumano/observatorio/docs/ansioliticos_hipnoticos- 2000-2012.pdf
AEMPS: Agencia Española del Medicamento y Productos Sanitarios. Observatorio del Uso de Medicamentos. Utilización de Medicamentos Antidepresivos en España Durante el Periodo 2000-2013. [Internet]. Madrid: AEMPS; 2015 [actualizado 14 enero 2015; citado 10 febrero 2018] Disponible en: https://www.aemps.gob.es/medicamentosUsoHumano/observatorio/docs/antidepresivos-2000- 2013.pdf
Álamo González C, Alonso Álvarez ML, Cañellas Dols F, Martín Águeda B, Pérez Díaz H, Romero Santos-Tomás O et al. Pauta de Actuación y Seguimiento: Insomnio. Madrid: Sociedad Española del Sueño; 2016.
Aparicio Basuri, Arbesú Prieto J, Guerrero Iturralde A, Iglesias Rivero R, Martínez Acebal A, Noriega Morán M et al. Guía de Recomendaciones Clínicas: Ansiedad. Asturias: Consejería de Sanidad y Servicios del Principado de Asturias; 2006.
Caballero Navarro A, Fernández Rodríguez I, Fernández Rodríguez M, García García L, García Haro J, García Velasco G et al. Guía de Recomendaciones Clínicas: Depresión. Asturias: Consejería de Sanidad y Servicios Sanitarios del Principado de Asturias; 2013.
Contreras A. Insomnio: Generalidades y Alternativas Terapéuticas de Última Generación.
Similar Articles
- María Mercedes Remón Álvarez-Arenas, Estefanía Morales Gama, María del Rosario Palomero Gil, Pharmacotherapeutic Approach to Anxiety at the Chemist’s , FarmaJournal: Vol. 7 No. 1 (2022)
- Adrián López, María Dolores Santos, María José García, Oral drug absorption predictions using “in silico” models (SIMCYP®): Statins , FarmaJournal: Vol. 2 No. 2 (2017)
- Lucía Cubero de Blas, Lola Parra Astorgano, Analysis of insomnia pharmacotherapy dispensation in community pharmacy 2015-2022 , FarmaJournal: Vol. 8 No. 2 (2023)
- Ana Belén Maestre Hernández, María Gonzalez Valdivieso, Josep Arasa, Elsa López Pintor, Study Review of the advantages and disadvantages of Dose Administration Aids (DDA) and evaluation of their adequacy to the patient's profile and type of pharmacy , FarmaJournal: Vol. 5 No. 1 (2020)
- Julia Ausin, Javier Tascón, Alfredo G. Casanova, Laura Vicente-Vicente, Ana I. Morales, Marta Prieto, Nephrotoxicity Associated with the Combination of Cisplatin and Immune Checkpoint Inhibitors. Histopathological Study , FarmaJournal: Vol. 9 No. 1 (2024)
- Jesús Morán, Darwin A Moreno-Pérez, Manuel A Patarroyo, Antonio Muro, Malaria proteomic research , FarmaJournal: Vol. 1 No. 1 (2016)
- Victoria Joaquina Villasán, Rebeca Vaquero Velasco, María Aurora Calleja, Anxiolytics and its Consume Increase as a Result of COVID-19 and “Pandemic Fatigue” , FarmaJournal: Vol. 7 No. 1 (2022)
- Elena Díaz, María Dolores Santos, Therapeutic Drug Monitoring of Lamotrigine in Pediatric Patients , FarmaJournal: Vol. 6 No. 1 (2021)
- María Sánchez Cueto, Aránzazu Zarzuelo Castañeda, Design and evaluation of cosmetics with apple vinegar and extract , FarmaJournal: Vol. 4 No. 2 (2019)
- Laura Garrido de Gracia, María José de Jesús Valle, Aránzazu Zarzuelo Castañeda, Amparo Sánchez Navarro, Development of Mucoadhesive Oral Formulations Based on Resveratrol Liposomes , FarmaJournal: Vol. 10 No. 2 (2025)
You may also start an advanced similarity search for this article.